Fatty acid synthase inhibitory activity of dibenzocyclooctadiene lignans isolated from  Schisandra chinensis | Zendy

Na MinKyun | Zendy; Hung Tran Manh | Zendy; Oh Won Keun | Zendy; Min Byung Sun | Zendy; Lee Seung Ho | Zendy; Bae KiHwan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Fatty acid synthase inhibitory activity of dibenzocyclooctadiene lignans isolated from Schisandra chinensis

Author(s) -

Na MinKyun,

Hung Tran Manh,

Oh Won Keun,

Min Byung Sun,

Lee Seung Ho,

Bae KiHwan

Publication year - 2010

Publication title -

phytotherapy research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.019

H-Index - 129

eISSN - 1099-1573

pISSN - 0951-418X

DOI - 10.1002/ptr.3149

Subject(s) - schisandra , schisandra chinensis , fatty acid synthase , inhibitory postsynaptic potential , traditional medicine , biochemistry , fatty acid , chemistry , atp synthase , biology , stereochemistry , medicine , enzyme , traditional chinese medicine , alternative medicine , pathology , neuroscience

Inhibition of fatty acid synthase (FAS) has been proposed to be a new therapeutic target for the treatment of cancer and obesity. In our preliminary screening study on the FAS inhibitory activity, a n ‐hexane soluble fraction prepared from the fruit of Schisandra chinensis (Schisandraceae) was found to inhibit FAS activity at 100 μg/mL. Nine dibenzocyclooctadiene lignans were isolated from the active fraction and were evaluated for their inhibitory effect on FAS for the first time. The compounds possessing a benzoyl or tigloyl group in the dibenzocyclooctadiene skeleton entirely inhibited the FAS activity in a dose dependent manner. The findings may be partially related to the anticancer effect of the medicinal plant, suggesting a further study on the anticancer potential of dibenzocyclooctadiene derivatives. Copyright © 2010 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research